{
    "organizations": [],
    "uuid": "4d56c4800e9e53ec5e61f69abc171d40d09b903f",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-shandong-xinhua-pharmaceutical-pos/brief-shandong-xinhua-pharmaceutical-posts-q1-operating-income-of-rmb1-42-bln-idUSFWN1RW0D3",
    "ord_in_thread": 0,
    "title": "BRIEF-Shandong Xinhua Pharmaceutical Posts Q1 Operating Income Of RMB1.42 Bln",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "April 19 (Reuters) - Shandong Xinhua Pharmaceutical Co Ltd :\n* Q1 OPERATING INCOME RMB1.42 BILLION VERSUS RMB1.30 BILLION\n* Q1 NET PROFIT ATTRIBUTABLE AFTER DEDUCTIONS RMB 65.2 MILLION VERSUS RMB 42.7 MILLION Source text for Eikon: Further company coverage:\n ",
    "published": "2018-04-19T16:41:00.000+03:00",
    "crawled": "2018-04-20T11:31:32.002+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "april",
        "reuters",
        "shandong",
        "xinhua",
        "pharmaceutical",
        "co",
        "ltd",
        "q1",
        "operating",
        "income",
        "billion",
        "versus",
        "billion",
        "q1",
        "net",
        "profit",
        "attributable",
        "deduction",
        "rmb",
        "million",
        "versus",
        "rmb",
        "million",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}